Cost-Effectiveness Analysis of Daclatasvir in Combination with Asunaprevir (DUAL) for the Treatment of Chronic Hepatitis C Patients in China

Value in Health ◽

10.1016/j.jval.2018.04.1067 ◽

2018 ◽

Vol 21 ◽

pp. S154

Author(s):

W CHENG ◽

W Chen

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Patients

Download Full-text

PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

Value in Health ◽

10.1016/j.jval.2011.08.889 ◽

2011 ◽

Vol 14 (7) ◽

pp. A394-A395

Author(s):

J. Areias ◽

T. Branco ◽

F. Calinas ◽

A. Carvalho ◽

G. Macedo ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Peginterferon Alfa ◽

Chronic Hepatitis C Patients

Download Full-text

Cost-Effectiveness Analysis Of A Personalized Therapy For Genotype 1, Naive, Chronic Hepatitis C Patients In Italy

Value in Health ◽

10.1016/j.jval.2014.08.819 ◽

2014 ◽

Vol 17 (7) ◽

pp. A366

Author(s):

S. Iannazzo ◽

P. Colombatto ◽

F. Bonino ◽

M.R. Brunetto

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Personalized Therapy ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Patients

Download Full-text

Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis

Digestive and Liver Disease ◽

10.1016/j.dld.2015.01.036 ◽

2015 ◽

Vol 47 ◽

pp. e15-e16 ◽

Author(s):

A. Ciaccio ◽

P.A. Cortesi ◽

G. Bellelli ◽

M. Rota ◽

S. Okolicsanyi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Oral Treatment ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Patients

Download Full-text

Cost‐effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis

Journal of Viral Hepatitis ◽

10.1111/jvh.13419 ◽

2020 ◽

Author(s):

Jocelyn Chan ◽

John J. Kim ◽

Brett K. Barrett ◽

Abdullah Hamadeh ◽

Jordan J. Feld ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Decompensated Cirrhosis ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Patients

Download Full-text

PIN45 COST-EFFECTIVENESS ANALYSIS OF TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B BOTH PLUS RIBAVIRIN IN SPAIN

Value in Health ◽

10.1016/s1098-3015(11)72843-1 ◽

2010 ◽

Vol 13 (7) ◽

pp. A438

Author(s):

P Ventayol-Bosch ◽

C Rubio-Terrés ◽

J García-Samaniego ◽

R Planas ◽

R Solà-Lamoglia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Peginterferon Alfa ◽

Chronic Hepatitis C Patients

Download Full-text

P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis

Journal of Hepatology ◽

10.1016/s0168-8278(15)31014-x ◽

2015 ◽

Vol 62 ◽

pp. S639

Author(s):

A. Ciaccio ◽

P.A. Cortesi ◽

G. Bellelli ◽

Matteo Rota ◽

Monica Rota ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Direct Acting Antivirals ◽

Effectiveness Analysis ◽

Direct Acting ◽

Chronic Hepatitis C Patients

Download Full-text

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of Viral Hepatitis ◽

10.1111/jvh.12278 ◽

2014 ◽

Vol 22 (2) ◽

pp. 175-183 ◽

Author(s):

P. A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

J. K. Lim ◽

S. De Salvia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Naïve

Download Full-text

Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir In Treatment Of Chronic Hepatitis C In The Russian Federation

Value in Health ◽

10.1016/j.jval.2016.09.397 ◽

2016 ◽

Vol 19 (7) ◽

pp. A415

Author(s):

R Yagudina ◽

A Kulikov ◽

VV Babiy

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Russian Federation ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

The Russian Federation

Download Full-text

Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil

Cost Effectiveness and Resource Allocation ◽

10.1186/1478-7547-11-25 ◽

2013 ◽

Vol 11 (1) ◽

pp. 25 ◽

Author(s):

Fabio MR Barros ◽

Hugo Cheinquer ◽

Carolina T Tsuchiya ◽

Eduardo AV Santos

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Payer Perspective ◽

Public Payer ◽

Peginterferon Alfa

Download Full-text

PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria

Value in Health ◽

10.1016/j.jval.2012.08.1109 ◽

2012 ◽

Vol 15 (7) ◽

pp. A392

Author(s):

M. Said ◽

A. Dragosits ◽

E. Walter

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text